Search Results - "BELLINGER, D. A."

Refine Results
  1. 1

    Molecular Characterization of Cat Factor XII Gene and Identification of a Mutation Causing Factor XII Deficiency in a Domestic Shorthair Cat Colony by Bender, D. E., Kloos, M. T., Pontius, J. U., Hinsdale, M. E., Bellinger, D. A.

    Published in Veterinary pathology (01-03-2015)
    “…Coagulation factor XII (FXII) may be important in cardiovascular and inflammatory diseases. We have identified and characterized a naturally occurring mutation…”
    Get full text
    Journal Article
  2. 2

    Direct intramuscular injection with recombinant AAV vectors results in sustained expression in a dog model of hemophilia by MONAHAN, P. E, SAMULSKI, R. J, TAZELAAR, J, XIAO, X, NICHOLS, T. C, BELLINGER, D. A, READ, M. S, WALSH, C. E

    Published in Gene therapy (1998)
    “…A recombinant adeno-associated virus (rAAV) vector carrying the human factor IX cDNA was tested for safety and therapeutic gene expression in a canine model of…”
    Get full text
    Journal Article
  3. 3

    Persistent expression of canine factor IX in hemophilia B canines by CHAO, H, SAMULSKI, R. J, BELLINGER, D. A, MONAHAN, P. E, NICHOLS, T. C, WALSH, C. E

    Published in Gene therapy (01-10-1999)
    “…We previously demonstrated that direct intramuscular injection of recombinant adeno-associated virus (rAAV) carrying the human FIX (hFIX) cDNA can safely be…”
    Get full text
    Journal Article
  4. 4

    Intravenous administration of an AAV-2 vector for the expression of factor IX in mice and a dog model of hemophilia B by HARDING, T. C, KOPRIVNIKAR, K. E, NICHOLS, T. C, BELLINGER, D. A, YENDLURI, S, WAUGH, J, MCARTHUR, J, VERES, G, DONAHUE, B. A, TU, G. H, ZAYEK, N, LEW, S, SUBRAMANIAN, A, SIVAKUMARAN, A, FREY, D, HO, K, VANROEY, M. J

    Published in Gene therapy (01-01-2004)
    “…Previous experiments have demonstrated the stable expression of factor IX (FIX) protein in mice and canine models of hemophilia B following portal vein gene…”
    Get full text
    Journal Article
  5. 5

    Lack of persistence of E1- recombinant adenoviral vectors containing a temperature-sensitive E2A mutation in immunocompetent mice and hemophilia B dogs by Fang, B, Wang, H, Gordon, G, Bellinger, D A, Read, M S, Brinkhous, K M, Woo, S L, Eisensmith, R C

    Published in Gene therapy (01-03-1996)
    “…Two recombinant adenoviruses expressing either human alpha 1-antitrypsin (hAAT) or canine factor IX (cFIX) were modified so that they also contained a…”
    Get more information
    Journal Article
  6. 6
  7. 7

    An anti-αVβ3 antibody inhibits coronary artery atherosclerosis in diabetic pigs by Maile, L.A, Busby, W.H, Xi, G, Gollahan, K.P, Flowers, W, Gafbacik, N, Gafbacik, S, Stewart, K, Merricks, E.P, Nichols, T.C, Bellinger, D.A, Clemmons, D.R

    Published in Atherosclerosis (01-03-2017)
    “…Abstract Background and aims Diabetes is a major risk factor for the development of atherosclerosis. Hyperglycemia stimulates vascular smooth muscle cells (…”
    Get full text
    Journal Article
  8. 8

    Intratracheal administration of recombinant human factor IX (BeneFix) achieves therapeutic levels in hemophilia B dogs by Russell, K E, Read, M S, Bellinger, D A, Leitermann, K, Rup, B J, McCarthy, K P, Keith, Jr, J C, Khor, S P, Schaub, R G, Nichols, T C

    Published in Thrombosis and haemostasis (01-03-2001)
    “…The purpose of this paper was to establish proof of concept for administration of human recombinant F.IX (rF.IX) by inhalation for therapy of hemophilia B. The…”
    Get more information
    Journal Article
  9. 9

    Gene therapy for hemophilia B: host immunosuppression prolongs the therapeutic effect of adenovirus-mediated factor IX expression by Fang, B, Eisensmith, R C, Wang, H, Kay, M A, Cross, R E, Landen, C N, Gordon, G, Bellinger, D A, Read, M S, Hu, P C

    Published in Human gene therapy (01-08-1995)
    “…Hemophilia B is caused by a deficiency of blood clotting factor IX (FIX). Previous studies have shown that the delivery of a recombinant adenoviral vector…”
    Get more information
    Journal Article
  10. 10
  11. 11

    Protein Replacement Therapy and Gene Transfer in Canine Models of Hemophilia A, Hemophilia B, von Willebrand Disease, and Factor VII Deficiency by Nichols, Timothy C, Dillow, Aaron M, Franck, Helen W.G, Merricks, Elizabeth P, Raymer, Robin A, Bellinger, Dwight A, Arruda, Valder R, High, Katherine A

    Published in ILAR journal (2009)
    “…Dogs with hemophilia A, hemophilia B, von Willebrand disease (VWD), and factor VII deficiency faithfully recapitulate the severe bleeding phenotype that occurs…”
    Get full text
    Journal Article
  12. 12

    Prevention of spontaneous bleeding in dogs with haemophilia A and haemophilia B by NICHOLS, T. C., RAYMER, R. A., FRANCK, H. W. G., MERRICKS, E. P., BELLINGER, D. A., DeFRIESS, N., MARGARITIS, P., ARRUDA, V. R., KAY, M. A., HIGH, K. A.

    “…Dogs with haemophilia A or haemophilia B exhibit spontaneous bleeding comparable with the spontaneous bleeding phenotype that occurs in humans with severe…”
    Get full text
    Journal Article
  13. 13

    Function of von Willebrand factor after crossed bone marrow transplantation between normal and von Willebrand disease pigs: effect on arterial thrombosis in chimeras by Nichols, T C, Samama, C M, Bellinger, D A, Roussi, J, Reddick, R L, Bonneau, M, Read, M S, Bailliart, O, Koch, G G, Vaiman, M

    “…von Willebrand factor (vWF) is essential for the induction of occlusive thrombosis in stenosed and injured pig arteries and for normal hemostasis. To separate…”
    Get full text
    Journal Article
  14. 14

    Familial and diet-induced hypercholesterolemia in swine : lipid, apoB, ApoA-I concentrations and distributions in plasma and lipoprotein subfractions by HASLER-RAPACZ, J. O, NICHOLS, T. C, GRIGGS, T. R, BELLINGER, D. A, RAPACZ, J

    Published in Arteriosclerosis and thrombosis (01-06-1994)
    “…Low levels of high-density lipoproteins (HDLs) may constitute an independent risk factor that may be as important as elevated low-density lipoproteins (LDLs)…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Correction of hemophilia B in canine and murine models using recombinant adeno-associated viral vectors by Kay, Mark A, Snyder, Richard O, Miao, Carol, Meuse, Leonard, Tubb, Julie, Donahue, Brian A, Lin, Hui-Feng, Stafford, Darrel W, Patel, Salil, Thompson, Arthur R, Nichols, Timothy, Read, Marjorie S, Bellinger, Dwight A, Brinkhous, Kenneth M

    Published in Nature medicine (01-01-1999)
    “…Hemophilia B, or factor IX deficiency, is an X-linked recessive disorder occurring in about 1 in 25,000 males. Affected individuals are at risk for spontaneous…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Oral Contraceptives and Hormone Replacement Therapy Do Not Increase the Incidence of Arterial Thrombosis in a Nonhuman Primate Model by Bellinger, Dwight A, Williams, J. Koudy, Adams, Michael R, Honore, Erika K, Bender, Diane E

    “…Older oral contraceptive (OC) formulations containing high doses of potent synthetic estrogens and progestins are associated with increased risk of thrombosis…”
    Get full text
    Journal Article
  20. 20

    Sustained Expression of Therapeutic Level of Factor IX in Hemophilia B Dogs by AAV-Mediated Gene Therapy in Liver by Wang, Lili, Nichols, Timothy C., Read, Marjorie S., Bellinger, Dwight A., Verma, Inder M.

    Published in Molecular therapy (01-02-2000)
    “…We demonstrate that a single intraportal vein injection of a recombinant adeno-associated virus (rAAV) vector encoding canine factor IX (cFIX) cDNA under the…”
    Get full text
    Journal Article